4 November 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use of bulevirtide in the NHS in England.

For the time being, bulevirtide acetate is not recommended for the treatment of adults with chronic hepatitis D with compensated liver disease.

Read NICE draft guidance consultation